Tran Dat T, Barake Walid, Galbraith Diane, Norris Colleen, Knudtson Merril L, Kaul Padma, McAlister Finlay A, Sandhu Roopinder K
Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
CJC Open. 2019 Jun 8;1(4):182-189. doi: 10.1016/j.cjco.2019.05.003. eCollection 2019 Jul.
Patients undergoing percutaneous coronary intervention (PCI) are increasingly older and have a higher comorbidity burden. This study evaluated trends in 30-day, 1-year, and 2-year total and cause-specific mortality using a large, contemporary cohort of patients who underwent PCI in Alberta, Canada.
We used the lberta rovincial oject for utcome ssessment in oronary eart Disease (APPROACH) registry to identify patients aged ≥ 20 years who underwent PCI between 2005 and 2013. All patients were followed until death or being censored by August 2016. Cause of death was from the Vital Statistics database and classified as cardiac or noncardiac. Multivariable logistic regression was used to calculate predicted mortality at 30 days, 1 year, and 2 years post-PCI.
Of the 35,602 patients who underwent PCI, 5284 (14.8%) had died. Mean (standard deviation) follow-up was 74.9 (35.1) months. Over the study period, patients were older and more likely to undergo PCI for an acute coronary syndrome indication. Thirty-day (2005: 1.3%; 2013: 3.2%; 0.001), 1-year (2005: 2.7%; 2013: 5.7%; 0.001), and 2-year (2005: 4.5%; 2013: 7.5%; 0.001) predicted mortality after PCI increased over the study period. Cardiac cause of death dominated in the short-term, but the proportion of noncardiac deaths increased as time from PCI to death increased (30 days = 11.5%, 1 year = 31.5%, 2 years = 39.6%; < 0.001).
In this population-based study, we found all-cause mortality at 30 days, 1 year, and 2 years after PCI increased over time. Cardiac causes of death dominate in the short-term after PCI; however, noncardiac cause becomes a major driver of mortality in the long-term.
接受经皮冠状动脉介入治疗(PCI)的患者年龄越来越大,合并症负担也越来越高。本研究使用加拿大艾伯塔省一个大型当代PCI患者队列,评估了30天、1年和2年全因死亡率及特定原因死亡率的趋势。
我们使用艾伯塔省冠状动脉疾病结局评估项目(APPROACH)登记处的数据,确定2005年至2013年间接受PCI的年龄≥20岁的患者。所有患者均随访至死亡或2016年8月被截尾。死亡原因来自生命统计数据库,分为心脏原因或非心脏原因。采用多变量逻辑回归计算PCI后30天、1年和2年的预测死亡率。
在35602例接受PCI的患者中,5284例(14.8%)死亡。平均(标准差)随访时间为74.9(35.1)个月。在研究期间,患者年龄更大,因急性冠状动脉综合征指征接受PCI的可能性更高。PCI后30天(2005年:1.3%;2013年:3.2%;P<0.001)、1年(2005年:2.7%;2013年:5.7%;P<0.001)和2年(2005年:4.5%;2013年:7.5%;P<0.001)的预测死亡率在研究期间有所增加。心脏原因导致的死亡在短期内占主导,但从PCI到死亡的时间增加时,非心脏原因导致的死亡比例增加(30天=11.5%,1年=31.5%,2年=39.6%;P<0.001)。
在这项基于人群的研究中,我们发现PCI后30天、1年和2年的全因死亡率随时间增加。心脏原因导致的死亡在PCI后短期内占主导;然而,非心脏原因在长期内成为死亡的主要驱动因素。